Attessa Capital
ABBV icon

Attessa Capital’s AbbVie ABBV Stock Holding History

Attessa Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$742K Sell
2,837
-601
-17% -$154K 0.32% 23
2026
Q2 		$865K Buy
3,438
+924
+37% +$199K 0.39% 20
2026
Q1 		$547K Sell
2,514
-38
-1% -$8.43K 0.3% 23
2025
Q4 		$583K Hold
2,552
– – 0.32% 20
2025
Q3 		$591K Hold
2,552
– – 0.35% 20
2025
Q2 		$474K Hold
2,552
– – 0.3% 22
2025
Q1 		$535K Sell
2,552
-128
-5% -$24.9K 0.35% 21
2024
Q4 		$476K Buy
+2,680
New +$493K 0.32% 25

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Attessa Capital's ABBV Position: Q3 2026 in Review

Attessa Capital reduced its AbbVie (ABBV) stake by 17% in Q3 2026, selling an estimated $154K and leaving 2,837 shares worth $742K. The position accounts for 0.32% of the portfolio, ranked #23.

Attessa Capital first reported a position in ABBV in Q4 2024 and has held it in 8 quarters since. The position peaked at $865K in Q2 2026. 3,188 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Attessa Capital held 2,837 shares of AbbVie worth $742K as of Q3 2026.
  • Attessa Capital sold 601 AbbVie shares in Q3 2026, an estimated $154K.
  • AbbVie made up 0.32% of Attessa Capital's portfolio in Q3 2026, its #23 holding.
  • Attessa Capital first reported a position in AbbVie in Q4 2024 and has held it in 8 quarters since.
  • Attessa Capital's AbbVie position peaked at $865K in Q2 2026.
  • 3,188 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Attessa Capital's 13F filing for Q3 2026, filed 9 Oct 2026.